Drug Shortage Report for NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
| Report ID | 264729 |
| Drug Identification Number | 02443295 |
| Brand name | NXSTAGE PUREFLOW SOLUTION RFP-209-CAN |
| Common or Proper name | Hemodialysis Solution |
| Company Name | NXSTAGE MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM CHLORIDE POTASSIUM CHLORIDE DEXTROSE SODIUM CHLORIDE SODIUM LACTATE MAGNESIUM CHLORIDE |
| Strength(s) | 0.221G 0.15G 1.1G 5.552G 8.408G 0.102G |
| Dosage form(s) | SOLUTION |
| Route of administration | HAEMODIALYSIS DIALYSIS |
| Packaging size | 5000 mL per bag/ Two (2) bags per shipping carton |
| ATC code | B05ZA |
| ATC description | HEMODIALYTICS AND HEMOFILTRATES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-12-31 |
| Actual start date | 2025-11-26 |
| Estimated end date | 2026-03-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 350 MERRIMACK STREET LAWRENCE, MASSACHUSETTS UNITED STATES 01843 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-11-27 | English | Compare |
| v4 | 2025-11-26 | French | Compare |
| v3 | 2025-11-26 | English | Compare |
| v2 | 2025-08-08 | French | Compare |
| v1 | 2025-08-08 | English | Compare |
Showing 1 to 5 of 5